Our story…
Montréal 2021 Scotia Virtual Race’s fundraising Campaign
The Covid-19 pandemic has affected all of us at so many levels. It is particularly challenging for patients diagnosed with glioblastoma, the most advanced brain tumor for adults. Patients and their families have to cope with this diagnosis, the fear and delays to access to standard treatment or to new clinical trials and the slow progress of research to develop novel therapies.
The Cancer Therapeutics Team at MUHC has been eagerly working to design an effective and affordable strategy in a pre-clinical study testing FDA-approved drug (Auranofin) in glioblastoma. This drug is readily available in prescription for rheumatoid Arthritis, well-known for its safety. Auranofin combined with radiation showed excellent results against brain tumor stem cells, known for their resistance to standard treatment with radiation and Temodal. The team will advance this drug from Lab research to use it in combination with radiation in a phase II clinical trial for patients with recurrent glioblastoma,
Please support the Cancer Therapeutics Team to reach their objective and bring new hope for patients with recurrent glioblastoma by clicking on the link below to make a secure online donation.
Thank you for your support, together we can make a difference before June 14, 2021
Team members
Click on one of our team members below to make a donation.
-
Bassam Abdulkarim
Raised: $250.00
Team captain
Recent donors
| Donation date | Donor name | Donation amount |
|---|---|---|
| Jun 14 | Bassam Abdulkarim Medical Practice | $2,000.00 |
| Jun 13 | Bertrand Jean-Claude | $500.00 |
| Jun 09 | Anonymous | $2,500.00 |
| Jun 08 | Anonymous | $100.00 |
| Jun 07 | Mountain Radiotherapy Associates | $5,000.00 |
| Jun 06 | Anonymous | $250.00 |
| Apr 04 | Bassam Abdulkarim | $250.00 |
